First Trust Advisors’s AnaptysBio ANAB Stock Holding History

First Trust Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.5M	Buy	+258,989	New	+$15.7M	0.01%	980
2019 Q1	–	Sell	-14,996	Closed	-$957K	–	2407
2018 Q4	$957K	Buy	+14,996	New	+$1.12M	﹤0.01%	1847
2018 Q3	–	Sell	-18,511	Closed	-$1.31M	–	2425
2018 Q2	$1.31M	Buy	+18,511	New	+$1.55M	﹤0.01%	1821

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

First Trust Advisors's ANAB Position: Q2 2026 in Review

First Trust Advisors opened a new position in AnaptysBio (ANAB) in Q2 2026: 258,989 shares worth $17.5M. The stake represents 0.01% of the portfolio and ranks #980 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in ANAB as recently as Q4 2018.

First Trust Advisors first reported a position in ANAB in Q2 2018 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

First Trust Advisors held 258,989 shares of AnaptysBio worth $17.5M as of Q2 2026.
AnaptysBio was a new First Trust Advisors position in Q2 2026.
AnaptysBio made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #980 holding.
First Trust Advisors first reported a position in AnaptysBio in Q2 2018 and has held it in 3 quarters since.
214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.